ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients

Share this content:
ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients
ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients

MONDAY, June 6, 2016 (HealthDay News) -- A novel antibody that targets claudin 18.2 is helping some patients with advanced gastric cancer live longer, according to a study presented at the annual meeting of the American Society of Clinical Oncology (ASCO), held from June 3 to 7 in Chicago.

The phase II clinical trial, involving 161 patients, focused on the antibody IMAB362. The median survival of patients using the treatment plus standard chemotherapy was 13.2 months, compared with 8.4 months for those who received chemotherapy alone, the researchers reported.

The IMAB362 antibody employed in this new treatment targets the claudin 18.2 protein. The researchers found that study patients who had the highest levels of this protein in tumors prior to receiving the new treatment had an even longer median overall survival, at 16.7 months.

"Since claudin 18.2 is abundant in gastric tumors, we estimate that half of all patients with advanced gastric cancer may be candidates for this new treatment," lead researcher Salah-Eddin Al-Batran, M.D., of the Institute of Clinical Cancer Research at Nordwest Hospital in Frankfurt, Germany, said in an ASCO news release. In addition, "this unique target is not present in any healthy tissues except the lining of the stomach, thereby minimizing treatment side effects."

The research was funded by Ganymed Pharmaceuticals, the manufacturer of IMAB362.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

24-Hour Primary Care Clinics Would Improve Continuity of Care

24-Hour Primary Care Clinics Would Improve Continuity of ...

Model involving multiple doctors working shifts in their own clinic offers many benefits

Repeat BP Reading Needed in Children With Initial High Result

Repeat BP Reading Needed in Children With Initial ...

Based on initial reading, more than half of children would have incorrect classification

Brochure Can Improve Opioid Disposal Rates After Surgery

Brochure Can Improve Opioid Disposal Rates After Surgery

Patients more likely to dispose of unused opioids after getting information and recommendations

is free, fast, and customized just for you!

Already a member?

Sign In Now »